UnknownPhase 4

Effect of Subarachnoid Hyperbaric Bupivacaine in Obese Pregnant Patients Undergoing Cesarean Section

Mexico106 participantsStarted 2023-08-01

Plain-language summary

Evaluates the effect of hyperbaric subarachnoid bupivacaine at doses of 5 mg vs 10 mg on mean arterial pressure in obese pregnant patients undergoing cesarean section

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnancy ≥37 weeks gestation with single fetus * Body mass index (BMI) ≥ 30 kg/m2 * Indication of termination of pregnancy via abdominal caesarean section * Indication of subarachnoid neuraxial block under mixed technique * Signing of consent under information Exclusion Criteria: * Allergy to local anesthetics * Psychiatric treatment (antidepressants, anxiolytics, antipsychotics) * Addiction to any type of drug * Liver, renal, pulmonary or cardiac disease * High blood pressure * Type I, II and gestational diabetes * Diagnostic of non-calming fetal state

What they're measuring

Assess the mean blood pressure

Timeframe: 3 hour

Determine the effects on the heart rate

Timeframe: 3 hour

Determine the effects on the O2 saturation

Timeframe: 3 hour

Trial details

NCT IDNCT06060015

SponsorHospital Civil de Guadalajara

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-31

Contact for this trial

María de los Angeles Campechano Ascencio, MSc

+5213310233983 angelescampechano@hotmail.com

View on ClinicalTrials.gov More Anesthesia trials